- Investing Ideas
- /
- French High Growth Potential Companies
French High Growth Potential Companies
Results
175
2 new
Companies with a Future performance score of at least 3, ordered by Future performance score.
175 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
ALLGO | €2.40 | 1.3% | 9.1% | €8.4m | €5.20 | PS0.3x | E110.4% | n/a | Retail | ||
VU | €168.60 | -3.0% | 39.3% | €2.7b | €203.00 | PS3.3x | E83.9% | 0.2% | Tech | ||
MLLCB | €3.16 | 1.9% | -24.0% | €13.5m | €4.92 | n/a | E37.3% | n/a | Real Estate Management and Development | ||
ALONC | €14.42 | 0% | 57.3% | €99.4m | €18.64 | PS3x | E101.2% | n/a | Pharmaceuticals & Biotech | ||
TKO | €21.05 | 1.2% | 3.2% | €3.6b | €26.85 | PE22.3x | E34.3% | 3.6% | Diversified Financials | ||
ALMUN | €0.60 | -6.3% | -40.6% | €5.3m | €1.30 | PS0.3x | E173.0% | n/a | Tech | ||
BLC | €22.25 | -5.7% | -2.4% | €162.6m | €32.67 | PE22x | E33.5% | n/a | Healthcare | ||
ADOC | €6.32 | 7.1% | -39.2% | €97.7m | €6.30 | PS27.2x | E64.0% | n/a | Pharmaceuticals & Biotech | ||
FDE | €23.25 | 0.9% | -51.4% | €122.7m | €51.67 | PE12.6x | E20.7% | n/a | Energy | ||
VLA | €2.07 | -6.5% | -48.3% | €336.4m | €6.83 | PS2.1x | E4.6% | n/a | Pharmaceuticals & Biotech | ||
AELIS | €1.90 | -1.6% | -85.8% | €25.9m | €9.10 | PS2.4x | E33.8% | n/a | Pharmaceuticals & Biotech | ||
ALPHE | €2.00 | 2.6% | -53.6% | €14.4m | €5.80 | PS4.6x | E78.8% | n/a | Pharmaceuticals & Biotech | ||
MEDCL | €16.30 | -1.1% | 100.5% | €476.4m | €22.83 | PS36.1x | E115.4% | n/a | Pharmaceuticals & Biotech | ||
ALHGR | €5.60 | 8.1% | -41.8% | €81.9m | €15.73 | PS10.7x | E126.7% | n/a | Materials | ||
VK | €18.70 | 5.0% | 36.2% | €4.4b | €20.81 | PE11.1x | E20.2% | 0% | Energy | ||
OVH | €8.40 | 8.7% | -10.9% | €1.6b | €9.84 | PS1.6x | E89.2% | n/a | Software | ||
ALSTI | €28.70 | 5.5% | 310.0% | €145.9m | €35.88 | PE29.7x | E21.9% | 0.7% | Capital Goods | ||
MLBMD | €8.00 | 0% | 0% | €37.6m | €19.25 | PS3.7x | E82.4% | n/a | Software | ||
AL2SI | €4.07 | -2.7% | 73.2% | €90.7m | €8.33 | PS0.7x | E72.9% | n/a | Tech | ||
ALSMA | €2.75 | 10.9% | -5.8% | €14.3m | €5.80 | PS2.1x | E103.8% | n/a | Healthcare | ||
GNFT | €3.36 | -2.0% | 7.2% | €167.5m | €9.45 | PE7.5x | E45.2% | n/a | Pharmaceuticals & Biotech | ||
ALCJ | €2.09 | -3.2% | -59.7% | €89.5m | €4.30 | PS38x | E101.6% | n/a | Healthcare | ||
ALMKT New | €0.18 | 2.5% | -60.5% | €11.5m | €2.00 | PS1.4x | E87.0% | n/a | Healthcare | ||
ALLIX | €10.06 | 0.4% | 22.7% | €66.6m | €13.50 | PS1.9x | E116.8% | n/a | Software |